The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes
Abstract
Background and Design Conflicting data exist about uric acid levels in type 2 diabetes mellitus, as low levels were found in diabetic patients, while elevated serum uric acid is a feature of hyperinsulinemia and impaired glucose tolerance. The present study was addressed to evaluate the relation between uric acid and metabolic parameters, creatinine clearance and albumin excretion rate in a cohort of type 2 diabetic patients. Results Hyperuricemic patients were older and had higher values of body mass index (BMI), systolic and diastolic blood pressure, triglycerides, albumin excretion rate, C‐peptide and prevalence of hypertension, metabolic syndrome and macroalbuminuria and lower values of high‐density lipoprotein (HDL)‐cholesterol, creatinine clearance and glycated haemoglobin (HbA 1c). The correlations between uric acid levels and triglycerides, BMI, systolic blood pressure, albumin excretion rate, C‐peptide, creatinine clearance, HDL‐cholesterol and HbA 1c remained significant in a multiple regression analysis after adjustment for age, sex and duration of diabetes. After performing multiple logistic regression analyses, uric acid levels were independently associated with hypertension [odds ratio (OR) = 1·8; 95% confidence interval (CI) 1·6–2], after adjustment for age, sex, duration of diabetes and macroalbuminuria (OR = 1·5; 95% CI 1·1–2·0), after adjustment for age, sex, HbA 1c levels, creatinine clearance, duration of diabetes and blood pressure levels and the metabolic syndrome (OR = 1·6; 95% CI 1·5–1·8), after adjustment for age, sex and creatinine clearance. Conclusions In type 2 diabetes, hyperuricemia seems to be associated with the insulin‐resistant syndrome and with early onset or increased progression to overt nephropathy, while hypouricemia is associated with worse metabolic control, hyperfiltration and a late onset or decreased progression to overt nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perry, I. J., Wannamethee, S. G., Walker, M. K., Thomson, A. G., Whincup, P. H., & Shaper, A. G. (1995) · BMJ · doi:10.1136/bmj.310.6979.560 · Cited by 532
Glycemic Control and Complications in Type II Diabetes: Design of a feasibility trial
Abraira, C., Emanuele, N., Colwell, J., Henderson, W., Comstock, J., Levin, S., Nuttall, F., Sawin, C., & VA CS Group (CSDM) (1992) · Diabetes Care · doi:10.2337/diacare.15.11.1560 · Cited by 44
Cited by
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Uric acid and chronic kidney disease: which is chasing which?
Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft029 · Cited by 654
Nakagawa, T., Tuttle, K. R., Short, R. A., & Johnson, R. J. (2005) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0019 · Cited by 382
Plasma uric acid and the risk of type 2 diabetes in a Chinese community
Chien, K.-L., Chen, M.-F., Hsu, H.-C., Chang, W.-T., Su, T.-C., Lee, Y.-T., & Hu, F. B. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095190 · Cited by 172
Metadata
- Authors
- Bo, S., Cavallo‐Perin, P., Gentile, L., Repetti, E., & Pagano, G.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 31
- Issue
- 4
- Pages
- 318-321
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1968250556
- Cited by
- 162
- References
- 2
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. https://app.cochat.ai/papers/10.1046/j.1365-2362.2001.00812.x
- The paper
- Bo, S., Cavallo‐Perin, P., Gentile, L., Repetti, E., & Pagano, G. (2001). Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.2001.00812.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.